TP53I3
Quinone oxidoreductase PIG3
Also known as: PIG3, QORX_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q53FA7
- Gene
- TP53I3
- Ensembl
- ENSG00000115129
- Chromosome
- 2
- Canonical length
- 332 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Vesicles
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is similar to oxidoreductases, which are enzymes involved in cellular responses to oxidative stresses and irradiation. This gene is induced by the tumor suppressor p53 and is thought to be involved in p53-mediated cell death. It contains a p53 consensus binding site in its promoter region and a downstream pentanucleotide microsatellite sequence. P53 has been shown to transcriptionally activate this gene by interacting with the downstream pentanucleotide microsatellite sequence. The microsatellite is polymorphic, with a varying number of pentanucleotide repeats directly correlated with the extent of transcriptional activation by p53. It has been suggested that the microsatellite polymorphism may be associated with differential susceptibility to cancer. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2011]
Canonical amino-acid sequenceUniProt
332 residues, UniProt reviewed canonical sequence.
>Q53FA7|TP53I3
1 MLAVHFDKPG GPENLYVKEV AKPSPGEGEV LLKVAASALN RADLMQRQGQ YDPPPGASNI
61 LGLEASGHVA ELGPGCQGHW KIGDTAMALL PGGGQAQYVT VPEGLLMPIP EGLTLTQAAA
121 IPEAWLTAFQ LLHLVGNVQA GDYVLIHAGL SGVGTAAIQL TRMAGAIPLV TAGSQKKLQM
181 AEKLGAAAGF NYKKEDFSEA TLKFTKGAGV NLILDCIGGS YWEKNVNCLA LDGRWVLYGL
241 MGGGDINGPL FSKLLFKRGS LITSLLRSRD NKYKQMLVNA FTEQILPHFS TEGPQRLLPV
301 LDRIYPVTEI QEAHKYMEAN KNIGKIVLEL PQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TP53I3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 122 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 122 nTPM
- small intestine: 73 nTPM
- vagina: 64 nTPM
- colon: 56 nTPM
- kidney: 56 nTPM
- cervix: 54 nTPM
Single-cell type
- esophageal apical cells: 897 nCPM
- late spermatids: 296 nCPM
- conjunctival goblet cells: 259 nCPM
- esophageal suprabasal cells: 220 nCPM
- enterocytes: 199 nCPM
- late primary spermatocytes: 176 nCPM
Immune cell
- classical monocyte: 19 nTPM
- eosinophil: 17 nTPM
- myeloid DC: 16 nTPM
- intermediate monocyte: 13 nTPM
- basophil: 12 nTPM
- plasmacytoid DC: 7.1 nTPM
Brain region
- thalamus: 23 nTPM
- choroid plexus: 19 nTPM
- midbrain: 19 nTPM
- cerebral cortex: 16 nTPM
- white matter: 16 nTPM
- medulla oblongata: 15 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.66
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.51
- DepMap mean gene effect
- -0.19
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TP53I3 as an antibody target. Whether an autoantibody or antibody against TP53I3 could matter depends on whether native TP53I3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TP53I3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TP53I3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...